Myasthenia Gravis, MuSK
Neurology
Prevalence
5.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Myasthenia Gravis, MuSK?
There are 1 clinical trial targeting Myasthenia Gravis, MuSK tracked by BioSniper.
What is the prevalence of Myasthenia Gravis, MuSK?
The estimated prevalence of Myasthenia Gravis, MuSK is approximately 5.0 per 100,000 population.
Deep-dive into Myasthenia Gravis, MuSK
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis